Article info
PDFClinical science
Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine
- Correspondence to Maria Phylactou, Cornea and External Diseases, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK; phylactou.maria{at}gmail.com
Citation
Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine
Publication history
- Received March 24, 2021
- Revised April 14, 2021
- Accepted April 16, 2021
- First published April 28, 2021.
Online issue publication
June 23, 2021
Article Versions
- Previous version (23 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage